Yesterday, Oct. 15, 2015, 25 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $1,527,544.00.

Highlighted Stocks Traded by Insiders:

Ruby Tuesday (RT) - FREE Research Report

Golder Jill, who is EVP, Chief Financial Officer at Ruby Tuesday, sold 8,075 shares at $5.25 on Oct. 15, 2015. Following this transaction, the EVP, Chief Financial Officer owned 104,376 shares meaning that the stake was reduced by 7.18% with the 8,075-share transaction.

The shares most recently traded at $5.30, up $0.05, or 0.86% since the insider transaction. Historical insider transactions for Ruby Tuesday go as follows:

  • 4-Week # shares sold: 2,620
  • 12-Week # shares sold: 2,620
  • 24-Week # shares sold: 244,325

The average volume for Ruby Tuesday has been 423,500 shares per day over the past 30 days. Ruby Tuesday has a market cap of $322.8 million and is part of the services sector and leisure industry. Shares are down 21.93% year-to-date as of the close of trading on Thursday.

Ruby Tuesday, Inc., together with its subsidiaries, engages in the ownership, development, operation, and franchise of casual dining restaurants in the United States and internationally. Currently, there are no analysts who rate Ruby Tuesday a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RT - FREE

TheStreet Quant Ratings rates Ruby Tuesday as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and poor profit margins. Get the full Ruby Tuesday Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Corcept Therapeutics (CORT) - FREE Research Report

Lo Steven, who is VP Commercial Operations at Corcept Therapeutics, sold 53,033 shares at $3.82 on Oct. 15, 2015. Following this transaction, the VP Commercial Operations owned 0 shares meaning that the stake was reduced by 100% with the 53,033-share transaction.

The shares most recently traded at $3.99, up $0.17, or 4.26% since the insider transaction. Historical insider transactions for Corcept Therapeutics go as follows:

  • 4-Week # shares bought: 100,000
  • 4-Week # shares sold: 55,300
  • 12-Week # shares bought: 100,000
  • 12-Week # shares sold: 55,300
  • 24-Week # shares bought: 100,000
  • 24-Week # shares sold: 55,300

The average volume for Corcept Therapeutics has been 320,800 shares per day over the past 30 days. Corcept Therapeutics has a market cap of $394.5 million and is part of the health care sector and drugs industry. Shares are up 21.33% year-to-date as of the close of trading on Thursday.

Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders in the United States. Currently, there are 2 analysts who rate Corcept Therapeutics a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CORT - FREE

TheStreet Quant Ratings rates Corcept Therapeutics as a sell. Among the areas we feel are negative, one of the most important has been very high debt management risk by most measures. Get the full Corcept Therapeutics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Layne Christensen (LAYN) - FREE Research Report

Brown David A B, who is Chairman of the Board at Layne Christensen, bought 10,000 shares at $6.77 on Oct. 15, 2015. Following this transaction, the Chairman of the Board owned 35,213 shares meaning that the stake was boosted by 39.66% with the 10,000-share transaction.

The shares most recently traded at $7.00, up $0.23, or 3.25% since the insider transaction. Historical insider transactions for Layne Christensen go as follows:

  • 4-Week # shares bought: 66,536
  • 12-Week # shares bought: 159,036
  • 24-Week # shares bought: 287,510

The average volume for Layne Christensen has been 206,700 shares per day over the past 30 days. Layne Christensen has a market cap of $132.8 million and is part of the industrial goods sector and materials & construction industry. Shares are down 29.66% year-to-date as of the close of trading on Thursday.

Layne Christensen Company provides water management, construction, and drilling services in North America and internationally. Currently, there are no analysts who rate Layne Christensen a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LAYN - FREE

TheStreet Quant Ratings rates Layne Christensen as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full Layne Christensen Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.